flucytosine has been researched along with Leukemia, Myeloid, Acute in 22 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
Excerpt | Relevance | Reference |
---|---|---|
"Due to an increasing number of leukemic patients with invasive gingival aspergillosis during neutropenia (neutrophils <500 cells/microl for >10 days), we evaluated the efficacy of oral itraconazole prophylaxis for preventing this invasive infection at our hospital." | 7.71 | Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia. ( Fujihara, M; Kyo, T; Mikami, Y; Myoken, Y; Sugata, T, 2002) |
"We present six cases of fusariosis caused by Fusarium solani that were diagnosed over a three-year period in 166 adult patients undergoing chemotherapy for acute leukemia." | 4.77 | Diagnosis and successful treatment of fusariosis in the compromised host. ( Hoagland, M; Hood, AF; Jett-Goheen, M; Junkins, JM; Karp, JE; Merz, WG, 1988) |
"Due to an increasing number of leukemic patients with invasive gingival aspergillosis during neutropenia (neutrophils <500 cells/microl for >10 days), we evaluated the efficacy of oral itraconazole prophylaxis for preventing this invasive infection at our hospital." | 3.71 | Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia. ( Fujihara, M; Kyo, T; Mikami, Y; Myoken, Y; Sugata, T, 2002) |
"Infections with fluconazole-resistant Candida albicans isolate have rarely been described in clinical settings other than oropharyngeal candidiasis in patients with late-stage AIDS." | 3.69 | Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. ( Dix, S; Falconer, DJ; Geller, R; Gilmore, C; Nolte, FS; Parkinson, T; Williams, J; Wingard, JR, 1997) |
"In an attempt to decrease the risk for reactivation of life-threatening invasive aspergillosis (IA) during subsequent myelosuppression in patients with previously diagnosed IA who were receiving antileukemic treatment, we evaluated the role of intensive antifungal therapy with amphotericin B and 5-fluorocytosine administered prophylactically throughout the antileukemic regimen and induced granulocytopenia to prevent IA reactivation without compromising the intensive chemotherapy." | 3.67 | An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. ( Burch, PA; Karp, JE; Merz, WG, 1988) |
"A 60-year-old man with acute myeloid leukemia (AML) presented with multifocal muscle abscesses of the legs." | 1.51 | Multifocal muscle candidiasis of the legs in a patient with acute myeloid leukemia: A case report. ( Li, L; Yang, M; Yang, X; Yi, P; Zhang, Y, 2019) |
"Another patient with acute myelogenous leukemia developed a huge brain abscess with histopathologic findings suspicious of mucormycosis." | 1.35 | Current approaches to management of cerebral fungal infection in pediatric patients with hematologic disorders. ( Ichikawa, M; Kaneda, M; Kobayashi, R; Nakagawa, A; Sato, T; Suzuki, D, 2008) |
"Hepatic candidiasis has been increasingly recognized as a variant of disseminated candidiasis in immunocompromised patients." | 1.27 | Hepatic candidiasis: an increasing problem in immunocompromised patients. ( Feld, R; Haron, E; Hasselback, R; Matlow, A; Patterson, B; Tuffnell, P, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (59.09) | 18.7374 |
1990's | 4 (18.18) | 18.2507 |
2000's | 2 (9.09) | 29.6817 |
2010's | 3 (13.64) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ullmann, AJ | 1 |
Aguado, JM | 1 |
Arikan-Akdagli, S | 1 |
Denning, DW | 1 |
Groll, AH | 1 |
Lagrou, K | 1 |
Lass-Flörl, C | 1 |
Lewis, RE | 1 |
Munoz, P | 1 |
Verweij, PE | 1 |
Warris, A | 1 |
Ader, F | 1 |
Akova, M | 1 |
Arendrup, MC | 1 |
Barnes, RA | 1 |
Beigelman-Aubry, C | 1 |
Blot, S | 1 |
Bouza, E | 1 |
Brüggemann, RJM | 1 |
Buchheidt, D | 1 |
Cadranel, J | 1 |
Castagnola, E | 1 |
Chakrabarti, A | 1 |
Cuenca-Estrella, M | 1 |
Dimopoulos, G | 1 |
Fortun, J | 1 |
Gangneux, JP | 1 |
Garbino, J | 1 |
Heinz, WJ | 1 |
Herbrecht, R | 1 |
Heussel, CP | 1 |
Kibbler, CC | 1 |
Klimko, N | 1 |
Kullberg, BJ | 1 |
Lange, C | 1 |
Lehrnbecher, T | 1 |
Löffler, J | 1 |
Lortholary, O | 1 |
Maertens, J | 1 |
Marchetti, O | 1 |
Meis, JF | 1 |
Pagano, L | 1 |
Ribaud, P | 1 |
Richardson, M | 1 |
Roilides, E | 1 |
Ruhnke, M | 1 |
Sanguinetti, M | 1 |
Sheppard, DC | 1 |
Sinkó, J | 1 |
Skiada, A | 1 |
Vehreschild, MJGT | 1 |
Viscoli, C | 1 |
Cornely, OA | 1 |
Yi, P | 1 |
Yang, X | 1 |
Yang, M | 1 |
Zhang, Y | 1 |
Li, L | 1 |
Maurer, S | 1 |
Salih, HR | 1 |
Smirnow, I | 1 |
Lauer, UM | 1 |
Berchtold, S | 1 |
Burkert, M | 1 |
Fuhr, HG | 1 |
Mertelsmann, R | 1 |
Sato, T | 1 |
Kaneda, M | 1 |
Ichikawa, M | 1 |
Suzuki, D | 1 |
Nakagawa, A | 1 |
Kobayashi, R | 1 |
Rusthoven, JJ | 1 |
Feld, R | 2 |
Tuffnell, PG | 1 |
Kostiala, AA | 1 |
Kostiala, I | 1 |
Oelz, O | 2 |
Schaffner, A | 1 |
Frick, P | 1 |
Schaer, G | 1 |
Tokioka, M | 1 |
Fuchimoto, T | 1 |
Saito, K | 1 |
Uehara, H | 1 |
Fujiwara, E | 1 |
Shaikh, BS | 1 |
Appelbaum, PC | 1 |
Aber, RC | 1 |
Nolte, FS | 1 |
Parkinson, T | 1 |
Falconer, DJ | 1 |
Dix, S | 1 |
Williams, J | 1 |
Gilmore, C | 1 |
Geller, R | 1 |
Wingard, JR | 1 |
Myoken, Y | 2 |
Sugata, T | 2 |
Kyo, T | 2 |
Fujihara, M | 2 |
Mikami, Y | 2 |
Ribner, B | 1 |
Keusch, GT | 1 |
Hanna, BA | 1 |
Perloff, M | 1 |
Tsui, E | 1 |
Liang, R | 1 |
Ogata, K | 1 |
Tanabe, Y | 1 |
Iwakiri, K | 1 |
Ito, T | 1 |
Yamada, T | 1 |
Dan, K | 1 |
Nomura, T | 1 |
Zimmermann-Hölsi, MB | 1 |
Stahel, RA | 1 |
Vogt, P | 1 |
Merz, WG | 2 |
Karp, JE | 2 |
Hoagland, M | 1 |
Jett-Goheen, M | 1 |
Junkins, JM | 1 |
Hood, AF | 1 |
Garavelli, PL | 1 |
Michelone, G | 1 |
Cavanna, C | 1 |
Maccabruni, A | 1 |
Burch, PA | 1 |
Haron, E | 1 |
Tuffnell, P | 1 |
Patterson, B | 1 |
Hasselback, R | 1 |
Matlow, A | 1 |
Greene, WH | 1 |
Wiernik, PH | 1 |
1 review available for flucytosine and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Diagnosis and successful treatment of fusariosis in the compromised host.
Topics: Adult; Amphotericin B; Female; Flucytosine; Fusarium; Humans; Immune Tolerance; Leukemia; Leukemia, | 1988 |
21 other studies available for flucytosine and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; D | 2018 |
Multifocal muscle candidiasis of the legs in a patient with acute myeloid leukemia: A case report.
Topics: Abscess; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Candida tropicalis; Candidiasis; | 2019 |
Suicide gene‑armed measles vaccine virus for the treatment of AML.
Topics: Adult; Aged; Combined Modality Therapy; Female; Flucytosine; Fluorouracil; Follow-Up Studies; Genes, | 2019 |
Antimycotic combination therapy in patients with acute myeloblastic leukemia.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Administration Schedule; Drug Thera | 1989 |
Current approaches to management of cerebral fungal infection in pediatric patients with hematologic disorders.
Topics: Adolescent; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Central Nervous | 2008 |
Systemic infection by Rhodotorula spp. in the immunocompromised host.
Topics: Adult; Amphotericin B; Bone Marrow; Flucytosine; Humans; Ketoconazole; Leukemia, Myeloid, Acute; Liv | 1984 |
Susceptibility of fungi in mouthrinse specimens from patients with haematological malignancies.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Flucyto | 1984 |
Trichosporon capitatum: thrush-like oral infection, local invasion, fungaemia and metastatic abscess formation in a leukaemic patient.
Topics: Abscess; Adult; Amphotericin B; Blood; Female; Flucytosine; Humans; Leukemia, Myeloid, Acute; Mitosp | 1983 |
[A case of successfully treated candida tropicalis with 5-fluorocytosine in a patient of APL].
Topics: Aged; Candidiasis; Cytosine; Flucytosine; Humans; Leukemia, Myeloid, Acute; Male | 1982 |
Vertebral disc space infection and osteomyelitis due to Candida albicans in a patient with acute myelomonocytic leukemia.
Topics: Aged; Amphotericin B; Candidiasis; Flucytosine; Humans; Intervertebral Disc; Leukemia, Myeloid, Acut | 1980 |
Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug R | 1997 |
Early surgical management of invasive gingival aspergillosis in a neutropenic patient with leukemia: a case report.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Fluconazole; Flucytosine; Gingival | 1997 |
Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis, Oral; Capsules; | 2002 |
Combination amphotericin B-rifampin therapy for pulmonary aspergillosis in a leukemic patient.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Drug Synergism; Flucytosine; Humans; In Vitro | 1976 |
Successful treatment of focal hepatic candidiasis in a patient with acute myeloid leukaemia.
Topics: Adult; Amphotericin B; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Leukemia | 1991 |
Two cases of disseminated Trichosporon beigelii infection treated with combination antifungal therapy.
Topics: Adult; Amphotericin B; Drug Combinations; Flucytosine; Humans; Leukemia, Myeloid, Acute; Lymphoma, N | 1990 |
[Decrease in systemic fungal infections in hematological neoplasms with empirical use of amphotericin B therapy].
Topics: Amphotericin B; Creatinine; Drug Therapy, Combination; Flucytosine; Humans; Leukemia, Myeloid, Acute | 1989 |
[Incidence of mycotic infections in children with acute myeloblastic leukemia (AML)].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Clotrimazole; Drug Resistance, Micro | 1988 |
An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Drug Therapy, | 1988 |
Hepatic candidiasis: an increasing problem in immunocompromised patients.
Topics: Adult; Amphotericin B; Biopsy; Candida; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; | 1987 |
Candida endophthalmitis. Successful treatment in a patient with acute leukemia.
Topics: Adult; Amphotericin B; Candidiasis; Candidiasis, Oral; Exudates and Transudates; Flucytosine; Humans | 1972 |